Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 8, 2013, Pages 1173-1182

  Sabile, Adam A ^a   Arlt, Matthias J E ^a   Muff, Roman ^a   Husmann, Knut ^a   Hess, Daniel ^b   Bertz, Josefine ^a   Langsam, Bettina ^a   Aemisegger, Caroline ^c   Ziegler, Urs ^c   Born, Walter ^a   Fuchs, Bruno ^a  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Caprin 1; Cyr61; Metastasis; Orthotopic mouse model; Osteosarcoma; Stress granules

Indexed keywords

CAPRIN 1; CISPLATIN; CYSTEINE RICH PROTEIN 61; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OSTEOSARCOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TISSUE MICROARRAY;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BONE NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CISPLATIN; CYSTEINE-RICH PROTEIN 61; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; PHOSPHORYLATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSPLANTATION, HETEROLOGOUS;

EID: 84877318169     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.03.014     Document Type: Article

References (34)

1. Ottaviani G., Jaffe N. The epidemiology of osteosarcoma. Cancer Treat. Res. 2009, 152:3-13.
2. Fuchs B., Pritchard D.J. Etiology of osteosarcoma. Clin. Orthop. Relat. Res. 2002, 40-52.
3. Marina N., Gebhardt M., Teot L., Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 2004, 9:422-441.
4. Gorlick R. Current concepts on the molecular biology of osteosarcoma. Cancer Treat. Res. 2009, 152:467-478.
5. Jones K.B. Osteosarcomagenesis: modeling cancer initiation in the mouse. Sarcoma 2011, 694136.
6. Fromigue O., Hamidouche Z., Vaudin P., Lecanda F., Patino A., Barbry P., Mari B., Marie P.J. Cyr61 downregulation reduces osteosarcoma cell invasion, migration and metastases. J. Bone Miner. Res. 2011, 26:1533-1542.
7. Sabile A.A., Arlt M.J., Muff R., Bode B., Langsam B., Bertz J., Jentzsch T., Puskas G.J., Born W., Fuchs B. Cyr61 expression in Osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice. J. Bone Miner. Res. 2012, 27:58-67.
8. Lau L.F., Lam S.C. The CCN family of angiogenic regulators: the integrin connection. Exp. Cell Res. 1999, 248:44-57.
9. Chen C.C., Lau L.F. Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem. Cell Biol. 2009, 41:771-783.
10. Dhar A., Ray A. The CCN family proteins in carcinogenesis. Exp. Oncol. 2010, 32:2-9.
11. Kular L., Pakradouni J., Kitabgi P., Laurent M., Martinerie C. The CCN family: a new class of inflammation modulators?. Biochimie 2011, 93:377-388.
12. Lau L.F. CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol. Life Sci. 2011, 68:3149-3163.
13. Tamura I., Rosenbloom J., Macarak E., Chaqour B. Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways. Am. J. Physiol. Cell Physiol. 2001, 281:C1524-C1532.
14. Grill B., Wilson G.M., Zhang K.X., Wang B., Doyonnas R., Quadroni M., Schrader J.W. Activation/division of lymphocytes results in increased levels of cytoplasmic activation/proliferation-associated protein-1: prototype of a new family of proteins. J. Immunol. 2004, 172:2389-2400.
15. Wang B., David M.D., Schrader J.W. Absence of caprin-1 results in defects in cellular proliferation. J. Immunol. 2005, 175:4274-4282.
16. Drougat L., Stichelen S.O., Mortuaire M., Foulquier F., Lacoste A.S., Michalski J.C., Lefebvre T., Vercoutter-Edouart A.S. Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition. Biochim. Biophys. Acta 2012, 1820:1839-1848.
17. Solomon S., Xu Y., Wang B., David M.D., Schubert P., Kennedy D., Schrader J.W. Distinct structural features of caprin-1 mediate its interaction with G3BP-1 and its induction of phosphorylation of eukaryotic translation initiation factor 2alpha, entry to cytoplasmic stress granules, and selective interaction with a subset of mRNAs. Mol. Cell. Biol. 2007, 27:2324-2342.
18. Kolobova E., Efimov A., Kaverina I., Rishi A.K., Schrader J.W., Ham A.J., Larocca M.C., Goldenring J.R. Microtubule-dependent association of AKAP350A and CCAR1 with RNA stress granules. Exp. Cell Res. 2009, 315:542-555.
19. Saffari M., Dinehkabodi O.S., Ghaffari S.H., Modarressi M.H., Mansouri F., Heidari M. Identification of novel p53 target genes by cDNA AFLP in glioblastoma cells. Cancer Lett. 2009, 273:316-322.
20. Kaddar T., Rouault J.P., Chien W.W., Chebel A., Gadoux M., Salles G., Ffrench M., Magaud J.P. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation. Biol. Cell 2009, 101:511-524.
21. Graham F.L., van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973, 52:456-467.
22. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M.J., Sauter G., Kallioniemi O.P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 1998, 4:844-847.
23. Ruifrok A.C., Johnston D.A. Quantification of histochemical staining by color deconvolution. Anal. Quant. Cytol. Histol. 2001, 23:291-299.
24. Arimoto K., Fukuda H., Imajoh-Ohmi S., Saito H., Takekawa M. Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat. Cell Biol. 2008, 10:1324-1332.
25. Chou A.J., Gorlick R. Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert. Rev. Anticancer. Ther. 2006, 6:1075-1085.
26. Towers E.R., Kelly J.J., Sud R., Gale J.E., Dawson S.J. Caprin-1 is a target of the deafness gene Pou4f3 and is recruited to stress granules in cochlear hair cells in response to ototoxic damage. J. Cell Sci. 2011, 124:1145-1155.
27. Anderson P., Kedersha N. RNA granules. J. Cell Biol. 2006, 172:803-808.
28. Moeller B.J., Cao Y., Li C.Y., Dewhirst M.W. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004, 5:429-441.
29. Baguet A., Degot S., Cougot N., Bertrand E., Chenard M.P., Wendling C., Kessler P., Le Hir H., Rio M.C., Tomasetto C. The exon-junction-complex-component metastatic lymph node 51 functions in stress-granule assembly. J. Cell Sci. 2007, 120:2774-2784.
30. Kwon S., Zhang Y., Matthias P. The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response. Genes Dev. 2007, 21:3381-3394.
31. Eisinger-Mathason T.S., Andrade J., Groehler A.L., Clark D.E., Muratore-Schroeder T.L., Pasic L., Smith J.A., Shabanowitz J., Hunt D.F., Macara I.G., Lannigan D.A. Codependent functions of RSK2 and the apoptosis-promoting factor TIA-1 in stress granule assembly and cell survival. Mol. Cell 2008, 31:722-736.
32. Buchan J.R., Parker R. Eukaryotic stress granules: the ins and outs of translation. Mol. Cell 2009, 36:932-941.
33. Chen C.C., Young J.L., Monzon R.I., Chen N., Todorovic V., Lau L.F. Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling. EMBO J. 2007, 26:1257-1267.
34. Kim W.J., Back S.H., Kim V., Ryu I., Jang S.K. Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions. Mol. Cell. Biol. 2005, 25:2450-2462.